Immunomedics preclinical data

In a mouse model of lymphoma, 5 doses of 43 µg IV (19)-3s led to a survival rate of 75% compared to 0% for mice treated with peripheral blood mononuclear cells (PBMCs). Additionally, 63% of mice treat...